Switching Therapies in Multiple Sclerosis

被引:0
|
作者
Patricia K. Coyle
机构
[1] Stony Brook University Medical Center,Department of Neurology
来源
CNS Drugs | 2013年 / 27卷
关键词
Multiple Sclerosis; Multiple Sclerosis Patient; Progressive Multifocal Leukoencephalopathy; Natalizumab; Glatiramer Acetate;
D O I
暂无
中图分类号
学科分类号
摘要
There are currently nine approved disease modifying therapies for relapsing forms of multiple sclerosis, with six distinct mechanisms of action. All have side effects, and none are cures. When a patient cannot tolerate therapy, or there is unacceptable breakthrough disease activity, the most common approach is to change drug. No universal guidelines exist for switching therapy. This overview will propose switch principles and suggestions.
引用
收藏
页码:239 / 247
页数:8
相关论文
共 50 条
  • [31] Real world switching therapies analysis in a retro-prospective cohort of patients with multiple sclerosis
    Mallucci, G.
    Zito, A.
    Bergamaschi, R.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 696 - 697
  • [32] Emerging oral therapies for multiple sclerosis
    Cohen, B. A.
    Rieckmann, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (11) : 1922 - 1930
  • [33] Emerging multiple sclerosis oral therapies
    Rammohan, Kottil W.
    Shoemaker, Jennifer
    NEUROLOGY, 2010, 74 (01) : S47 - S53
  • [34] Development of new therapies for multiple sclerosis
    Gierach, Pawel
    Juszczak, Marek
    Glabinski, Andrzej
    AKTUALNOSCI NEUROLOGICZNE, 2009, 9 (02): : 132 - 139
  • [35] Estrogen and testosterone therapies in multiple sclerosis
    Gold, Stefan M.
    Voskuhl, Rhonda R.
    NEUROTHERAPY: PROGRESS IN RESTORATIVE NEUROSCIENCE AND NEUROLOGY, 2009, 175 : 239 - 251
  • [36] Assessing risks of multiple sclerosis therapies
    Parfenov, Valeriy
    Schluep, Myriam
    Du Pasquier, Renaud
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 332 (1-2) : 59 - 65
  • [37] Emerging Therapies for the Management of Multiple Sclerosis
    Namaka, Michael
    Leong, Christine
    Prout, Michael
    Le Dorze, Josee-Anne
    Limerick, Mike
    Frost, Emma
    Esfahani, Farid
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 307 - 319
  • [38] Alternative and complementary therapies in multiple sclerosis
    Apel-Neu, A.
    Greim, B.
    Koenig, N.
    Zettl, U. K.
    NERVENARZT, 2009, 80 : 20 - 21
  • [39] Approaches to Remyelination Therapies in Multiple Sclerosis
    Wooliscroft, Lindsey
    Silbermann, Elizabeth
    Cameron, Michelle
    Bourdette, Dennis
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (07)
  • [40] Emerging Oral Therapies in Multiple Sclerosis
    Devon Conway
    Jeffrey A. Cohen
    Current Neurology and Neuroscience Reports, 2010, 10 : 381 - 388